Sucozin 25 mg (Tablet)
Unit Price: ৳ 40.00 (1 x 10: ৳ 400.00)
Strip Price: ৳ 400.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Globe pharmaceuticals ltd |
| Also available as |
Indications
- Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
- To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease
Pharmacology
- Sodium glucose co-transporter-2 (SGLT-2) inhibitor
- Reduces renal absorption of glucose
- Increases glucose excretion
- Assists weight loss
- Lowers blood pressure
Dosage & Administration
- Recommended dose: 10 mg once daily
- May be increased to 25 mg once daily in patients tolerating the medication
- Can be taken with or without food
- In cases of volume depletion, correction is recommended prior to initiation
Interactions
- Co-administration with diuretics increases urine volume
- Co-administration with insulin or insulin secretagogues increases the risk for hypoglycemia
- Monitoring glycemic control with urine glucose tests not recommended
- Monitoring glycemic control with 1,5-anhydroglucitol assay not recommended
Contraindications
- History of serious hypersensitivity reaction to Empagliflozin or any of its ingredients
- Severe renal impairment
- End-stage renal disease
- Dialysis
Side Effects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
Pregnancy & Lactation
- Limited studies in pregnant women
- Use during pregnancy only if potential benefit justifies potential risk to fetus
- Not recommended while breastfeeding
Precautions & Warnings
- Assessment of renal function recommended prior to initiation
- Should not be initiated in patients with eGFR less than 45 ml/min/1.73 m^2
- No dose adjustment needed in patients with eGFR greater than or equal to 45 ml/min/1.73 m^2
Overdose Effects
- Usual supportive measures recommended in case of overdose
- Hemodialysis effectiveness not studied
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C23H27ClO7
- Chemical structure available
Common Questions about Sucozin 25 mg Tablet
- Used as a SGLT-2 inhibitor to reduce glucose reabsorption from the kidney
- Commonly used to improve glycemic control in adults
- Unsafe to use during pregnancy
- Probably unsafe to use during breastfeeding
- Should be used cautiously in patients with underlying kidney disease
- No dose adjustment needed for patients with mild to moderate liver disease
- Quick tips for usage and precautions